My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioXcel Therapeutics, Inc. - Common Stock (NQ:BTAI)

2.700 -0.120 (-4.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,306,809
Open 2.960
Bid (Size) 2.700 (2)
Ask (Size) 2.740 (157)
Prev. Close 2.820
Today's Range 2.660 - 2.960
52wk Range 1.170 - 13.28
Shares Outstanding 6,620,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioXcel Drug Calms Agitation At Home For Schizophrenia, Bipolar Patients
BioXcel's Phase 3 trial shows BXCL501 effectively reduces agitation in bipolar and schizophrenia patients, supporting its at-home treatment use. 
Via Benzinga
BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study
Via Stocktwits

Performance

YTD
-57.0%
-57.0%
1 Month
-31.8%
-31.8%
3 Month
+52.5%
+52.5%
6 Month
+27.4%
+27.4%
1 Year
-68.4%
-68.4%

More News

Read More
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
EXCLUSIVE: August's 20 Most-Searched Tickers On Benzinga Pro – Where Do Opendoor, Palantir, BitMine Immersion, Apple Stock Rank?
Via Benzinga
BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later
Via Stocktwits
BioXcel Sparks Retail Frenzy As Stock Soars Ahead Of Phase 3 Results For Bipolar, Schizophrenia Drug
Via Stocktwits
BioXcel Stock In Focus: FDA Issues Positive Early Feedback Ahead Of Key Meeting On Expanded Psychiatric Label
Via Stocktwits
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Which stocks are experiencing notable movement on Wednesday?
Via Chartmill
BioXcel Seeks FDA Label Expansion For Schizophrenia Treatment
Via Benzinga
The market is filled with gapping stocks in Wednesday's session.
Via Chartmill
Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BioXcel Stock Surges 19% In After-Hours Trading: What You Need To Know
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Get insights into the top gainers and losers of Tuesday's after-hours session.
Via Chartmill
Tuesday's pre-market session: top gainers and losers
Via Chartmill
Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!
Via AB Newswire
Topics Artificial Intelligence
BioXcel Therapeutics (BTAI) Stock Is Surging Monday: What's Going On?
Via Benzinga
Topics Artificial Intelligence
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BioXcel Stock In Focus: FDA Issues Positive Early Feedback Ahead Of Key Meeting On Expanded Psychiatric Label (This works)
Via Stocktwits
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Wondering what's happening in today's after-hours session?
Via Chartmill

Frequently Asked Questions

Is BioXcel Therapeutics, Inc. - Common Stock publicly traded?
Yes, BioXcel Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does BioXcel Therapeutics, Inc. - Common Stock trade on?
BioXcel Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioXcel Therapeutics, Inc. - Common Stock?
The ticker symbol for BioXcel Therapeutics, Inc. - Common Stock is BTAI on the Nasdaq Stock Market
What is the current price of BioXcel Therapeutics, Inc. - Common Stock?
The current price of BioXcel Therapeutics, Inc. - Common Stock is 2.700
When was BioXcel Therapeutics, Inc. - Common Stock last traded?
The last trade of BioXcel Therapeutics, Inc. - Common Stock was at 09/26/25 04:00 PM ET
What is the market capitalization of BioXcel Therapeutics, Inc. - Common Stock?
The market capitalization of BioXcel Therapeutics, Inc. - Common Stock is 17.87M
How many shares of BioXcel Therapeutics, Inc. - Common Stock are outstanding?
BioXcel Therapeutics, Inc. - Common Stock has 18M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.